FDA Clearance of LIA™ featuring LEADOPTIK
LIA™ (Last Inch Assessment) has officially received clearance from the U.S. Food and Drug Administration. On paper, this is a regulatory milestone. In practice, it represents a fundamental shift in how lung cancer can be approached at its most fragile and consequential moment.
